United States
AstraZeneca purchases Spirogen for USD440 million
British drugmaker AstraZeneca announced on Tuesday that it had purchased biotech company Spirogen in a deal worth USD440 million in total.
Creditors of Energy Future fight over equity split
Secured lenders at Texas Competitive Electric Holdings and unsecured bondholders at Energy Future Intermediate Holdings (EFIH) were in a deadlock about their confidentiality agreements due to Energy Future Holdings' USD250 bond debt payments due on November 1.
Capitol Bancorp inks deal to sell stock of consolidated entities to Talmer Bancorp
Capitol Bancorp has signed an agreement with Talmer Bancorp for the sale of the common stock of Capitol's consolidated entities.
Citigroup, State Street puts measures in place for potential US government debt default- report
A Wall Street Journal report said that Citigroup and State Street were already preparing for a possible debt default by the US government.